University of Münster
CRIS@UM
DE | EN

Dr.med. Martin Bögemann

Current affiliations

  • Clinic for Urology

Publications

Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands
Rahbar Nikoukar L, Seifert R, Ventura D, Schindler P, Bögemann M, Rahbar K, Roll W (2025)
In: Nuclear Medicine / Nuklearmedizin, 64(1).
Research article (journal)
Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients
Bredensteiner L, Ventura D, Rassek P, Schäfers M, Bögemann M, Schindler P, Weckesser M, Rahbar K, Roll W (2024)
In: Nuclear Medicine / Nuklearmedizin, 63(5).
Research article (journal)
Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET
Ventura D, Rassek P, Schindler P, Akkurt BH, Bredensteiner L, Bögemann M, Schlack K, Seifert R, Schäfers M, Roll W, Rahbar K (2024)
In: Cancer Imaging, 18(24(1)).
Research article (journal)
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer
Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017)
In: ((Bitte Journal prüfen)), 71.
Research article (journal)
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017)
In: ((Bitte Journal prüfen)), 18.
Research article (journal)
Show all publications